Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (81373282, 21302111)
  • National High-tech R&D Program of China (2014AA020523)
  • Major Project of Science and Technology of Shandong Province (2015ZDJS04001)
  • Young Scholars Program of Shandong University (2016 WLI H33)
  • National Institutes of Health/National Cancer Institute (CA163452 to C.J.C.)

This publication has 21 references indexed in Scilit: